title: Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.
authors.affiliation: Department of Rheumatology, Rouen University Hospital, 76031 Rouen Cedex, France. thierry.lequerre@univ-rouen.fr
authors.forename: T
authors.initials: T
authors.lastname: Lequerré
authors.forename: O
authors.initials: O
authors.lastname: Vittecoq
authors.forename: S
authors.initials: S
authors.lastname: Pouplin
authors.forename: N
authors.initials: N
authors.lastname: Klemmer
authors.forename: O
authors.initials: O
authors.lastname: Mejjad
authors.forename: A
authors.initials: A
authors.lastname: Daragon
authors.forename: A M
authors.initials: AM
authors.lastname: Prieur
authors.forename: X
authors.initials: X
authors.lastname: Le Loët
mesh_terms: D000328:Adult; D001168:Arthritis / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D054078:Mevalonate Kinase Deficiency / Q000150:complications* / Q000175:diagnosis; D010147:Pain Measurement; D020127:Recovery of Function; D016896:Treatment Outcome
chemical_list: D053590:Interleukin 1 Receptor Antagonist Protein